A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan
Clinical trial NCT06163040 · COMPLETED
Trial details
- NCT number
- NCT06163040
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-22
- Primary completion
- 2025-03-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.